Showing 121 - 140 results of 366 for search 'Miss Universe Denmark', query time: 0.24s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130

    Data quality in the Danish National Acute Leukemia Registry: a hematological data resource by Østgård LSG, Nørgaard JM, Severinsen MT, Sengeløv H, Friis L, Jensen MK, Nielsen OJ, Nørgaard M

    Published 2013-09-01
    “…Lene Sofie Granfeldt Østgård,1,2 Jan Maxwell Nørgaard,1 Marianne Tang Severinsen,3 Henrik Sengeløv,4 Lone Friis,5 Morten Krogh Jensen,6 Ove Juul Nielsen,7 Mette Nørgaard2 1Department of Hematology, 2Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Hematology, Aalborg University Hospital, Aalborg, Denmark; 4Department of Hematology, Rigshospitalet, Copenhagen, Denmark; 5Department of Hematology, Odense University Hospital, Odense, Denmark; 6Department of Hematology, Herlev Hospital, Herlev, Denmark; 7Department of Hematology, Rigshospitalet, Copenhagen, Denmark Background: The Danish National Acute Leukemia Registry (DNLR) has documented coverage of above 98.5%. …”
    Get full text
    Article
  11. 131
  12. 132
  13. 133

    AUD-DSS: a decision support system for early detection of patients with alcohol use disorder by Ali Ebrahimi, Uffe Kock Wiil, Ruben Baskaran, Abdolrahman Peimankar, Kjeld Andersen, Anette Søgaard Nielsen

    Published 2023-09-01
    “…Two data sources, including a questionnaire and electronic health records of 2571 patients, were collected from Odense University Hospital in the Region of Southern Denmark for the AUD-Dataset. …”
    Get full text
    Article
  14. 134

    A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer by Wagner T, Lauritsen J, Bandak M, Rasmussen LA, Bakker J, Hovaldt HB, Larsson H, Christensen IJ, Toft BG, Agerbæk M, Dysager L, Kreiberg M, Rosenvilde JJ, Engvad B, Berney DM, Daugaard G

    Published 2023-04-01
    “…Thomas Wagner,1,2 Jakob Lauritsen,1 Mikkel Bandak,1 Linda Aagaard Rasmussen,3 Johannes Bakker,4 Hanna Birkbak Hovaldt,4 Heidi Larsson,4 Ib Jarle Christensen,1 Birgitte Grønkær Toft,2 Mads Agerbæk,5 Lars Dysager,6 Michael Kreiberg,1 Josephine Julie Rosenvilde,1 Birte Engvad,7 Daniel M Berney,8 Gedske Daugaard1 1Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; 2Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; 3Research Unit for General Practice, Aarhus, Denmark; 4The Danish Clinical Quality Program – National Clinical Registries (RKKP), Aarhus, Odense and Copenhagen, Denmark; 5Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; 6Department of Oncology, Odense University Hospital, Odense, Denmark; 7Department of Pathology, Odense University Hospital, Odense, Denmark; 8Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UKCorrespondence: Thomas Wagner, Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark, Tel +45 35459682, Email thomas.wagner.nielsen@regionh.dkPurpose: The Danish Testicular Cancer (DaTeCa) database aims to monitor and improve quality of care for testicular cancer patients. …”
    Get full text
    Article
  15. 135
  16. 136
  17. 137
  18. 138

    Randomized clinical trials with run-in periods: frequency, characteristics and reporting by Laursen DRT, Paludan-Müller AS, Hróbjartsson A

    Published 2019-02-01
    “…David Ruben Teindl Laursen,1–4 Asger Sand Paludan-Müller,2 Asbjørn Hróbjartsson1,3,4 1Centre for Evidence-Based Medicine Odense (CEBMO), Odense University Hospital, Odense, Denmark; 2Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark; 3Department of Clinical Research, University of Southern Denmark, Odense, Denmark; 4Odense Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark Background: Run-in periods are occasionally used in randomized clinical trials to exclude patients after inclusion, but before randomization. …”
    Get full text
    Article
  19. 139
  20. 140